Celt ACD
Vascular Puncture Closure Device Coming to U.S.
Vasorum Ltd., an Irish Firm, won FDA approval to introduce its
Celt ACD
Vascular Closure Device in the
U.S. market. It’s already used in Europe to close arterial punctures following both diag**stic and interventional cath lab procedures. The
Device is inserted through the already positioned sheath at the end of the procedure, advanced through it, and when the handle is turned the distal tip morphs into a flat disk.*A**ther disk is positioned on the outside, and the two work together to create hemostasis at the
Puncture site.
“With more than 20,000 patient implants to date in Europe,
Celt ACD® has proven itself to be a best in class arterial
Puncture Closure device.
Celt ACD® allows immediate
Closure of multiple re-sticks in calcified vessels and is also very comfortable for patients. The FDA approval is a very significant milestone allowing US market entry by Vasorum,” stated James Coleman MD, co-founder and CEO of Vasorum.
Here’s an animation showing how the
Celt ACD works:
Product page:
Celt ACD…
This post
Celt ACD Vascular Puncture Closure Device Coming to U.S. appeared first on
Medgadget.
